Serum superoxide dismutase, a potential predictor for radiation pneumonitis following chemoradiotherapy in non-small cell lung cancer patients

Biomarkers

Volumn 17, Issue 5, 2012, Pages 455-462

  Wang, Dongqing ^a   Zhu, Jingyu ^b   Sun, Mingping ^a   Li, Baosheng ^a   Wei, Ling ^a   Wang, Zhongtang ^a   Sun, Hongfu ^a  

^a SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

^b JINAN CENTRAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Non small cell lung cancer; Radiation pneumonitis; Radiation therapy; Superoxide dismutase

Indexed keywords

CISPLATIN; CYTOKERATIN 19 FRAGMENT; FLUORODEOXYGLUCOSE F 18; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; CANCER PATIENT; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RADIATION DOSE; RADIATION PNEUMONIA; SENSITIVITY AND SPECIFICITY; TREATMENT DURATION; TREATMENT RESPONSE;

ANTIGENS, NEOPLASM; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOKINE CCL3; CHEMORADIOTHERAPY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; KERATIN-19; LUNG NEOPLASMS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIATION PNEUMONITIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUPEROXIDE DISMUTASE; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1; TREATMENT OUTCOME;

EID: 84864591438     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2012.685952     Document Type: Article

References (40)

1. Anscher MS, Kong FM, Marks LB, Bentel GC, Jirtle RL. (1997). Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis. Int J Radiat Oncol Biol Phys 37:253-258.
2. Arpin D, Perol D, Blay JY, Falchero L, Claude L, Vuillermoz-Blas S, Martel-Lafay I, Ginestet C, Alberti L, Nosov D, Etienne-Mastroianni B, Cottin V, Perol M, Guerin JC, Cordier JF, Carrie C. (2005). Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis. J Clin Oncol 23:8748-8756.
3. Barriger RB, Fakiris AJ, Hanna N, Yu M, Mantravadi P, McGarry RC. (2010). Dose-volume analysis of radiation pneumonitis in nonsmall- cell lung cancer patients treated with concurrent cisplatinum and etoposide with or without consolidation docetaxel. Int J Radiat Oncol Biol Phys 78:1381-1386.
4. Bowler RP, Nicks M, Warnick K, Crapo JD. (2002). Role of extracellular superoxide dismutase in bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 282:L719-L726.
5. Chen Y, Rubin P, Williams J, Hernady E, Smudzin T, Okunieff P. (2001). Circulating IL-6 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys 49:641-648.
6. Chen Y, Williams J, Ding I, Hernady E, Liu W, Smudzin T, Finkelstein JN, Rubin P, Okunieff P. (2002). Radiation pneumonitis and early circulatory cytokine markers. Semin Radiat Oncol 12:26-33.
7. Chen Y, Hyrien O, Williams J, Okunieff P, Smudzin T, Rubin P. (2005). Interleukin (IL)-1A and IL-6: Applications to the predictive diagnostic testing of radiation pneumonitis. Int J Radiat Oncol Biol Phys 62:260-266.
8. De Jaeger K, Seppenwoolde Y, Kampinga HH, Boersma LJ, Belderbos JS, Lebesque JV. (2004). Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 58:1378-1387.
9. Erasmus JJ, Gladish GW, Broemeling L, Sabloff BS, Truong MT, Herbst RS, Munden RF. (2003). Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: Implications for assessment of tumor response. J Clin Oncol 21:2574-2582.
10. Evans ES, Kocak Z, Zhou SM, Kahn DA, Huang H, Hollis DR, Light KL, Anscher MS, Marks LB. (2006). Does transforming growth factorbeta1 predict for radiation-induced pneumonitis in patients treated for lung cancer Cytokine 35:186-192.
11. Fattman CL, Chu CT, Kulich SM, Enghild JJ, Oury TD. (2001). Altered expression of extracellular superoxide dismutase in mouse lung after bleomycin treatment. Free Radic Biol Med 31:1198-1207.
12. Gupta A, Srivastava S, Prasad R, Natu SM, Mittal B, Negi MP, Srivastava AN. (2010). Oxidative stress in non-small cell lung cancer patients after chemotherapy: Association with treatment response. Respirology 15:349-356.
13. Hart JP, Broadwater G, Rabbani Z, Moeller BJ, Clough R, Huang D, Sempowski GA, Dewhirst M, Pizzo SV, Vujaskovic Z, Anscher MS. (2005). Cytokine profiling for prediction of symptomatic radiation-induced lung injury. Int J Radiat Oncol Biol Phys 63: 1448-1454.
14. Hartsell WF, Scott CB, Dundas GS, Mohiuddin M, Meredith RF, Rubin P, Weigensberg IJ. (2007). Can serum markers be used to predict acute and late toxicity in patients with lung cancer Analysis of RTOG 91-03. Am J Clin Oncol 30:368-376.
15. Hildebrandt MA, Komaki R, Liao Z, Gu J, Chang JY, Ye Y, Lu C, Stewart DJ, Minna JD, Roth JA, Lippman SM, Cox JD, Hong WK, Spitz MR, Wu X. (2010). Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. PLoS ONE 5:e12402.
16. Kim JY, Kim YS, Kim YK, Park HJ, Kim SJ, Kang JH, Wang YP, Jang HS, Lee SN, Yoon SC. (2009). The TGF-beta1 dynamics during radiation therapy and its correlation to symptomatic radiation pneumonitis in lung cancer patients. Radiat Oncol 4:59.
17. Kocak Z, Borst GR, Zeng J, Zhou S, Hollis DR, Zhang J, Evans ES, Folz RJ, Wong T, Kahn D, Belderbos JS, Lebesque JV, Marks LB. (2007). Prospective assessment of dosimetric/physiologic-based models for predicting radiation pneumonitis. Int J Radiat Oncol Biol Phys 67:178-186.
18. Kong FM, Ao X, Wang L, Lawrence TS. (2008). The use of blood biomarkers to predict radiation lung toxicity: A potential strategy to individualize thoracic radiation therapy. ancer Control 15:140-150.
19. Mak RH, Alexander BM, Asomaning K, Heist RS, Liu CY, Su L, Zhai R, Ancukiewicz M, Napolitano B, Niemierko A, Willers H, Choi NC, Christiani DC. (2011). A single-nucleotide polymorphism in the MTHFR (methylene tetrahydrofolate reductase) gene is associated with risk of radiation pneumonitis in lung cancer patients treated with thoracic radiation therapy. Cancer doi: 10.1002/cncr.26667.
20. Mazeron R, Etienne-Mastroianni B, Pol D, Arpin D, Vincent M, Falchero L, Martel-Lafay I, Carrie C, Claude L. (2010). Predictive factors of late radiation fibrosis: A prospective study in non-small cell lung cancer. Int J Radiat Oncol Biol Phys 77:38-43.
21. Novakova-Jiresova A, Van Gameren MM, Coppes RP, Kampinga HH, Groen HJ. (2004). Transforming growth factor-beta plasma dynamics and post-irradiation lung injury in lung cancer patients. Radiother Oncol 71:183-189.
22. Park EM, Ramnath N, Yang GY, Ahn JY, Park Y, Lee TY, Shin HS, Yu J, Ip C, Park YM. (2007). High superoxide dismutase and low glutathione peroxidase activities in red blood cells predict susceptibility of lung cancer patients to radiation pneumonitis. Free Radic Biol Med 42:280-287.
23. Phernambucq EC, Spoelstra FO, Verbakel WF, Postmus PE, Melissant CF, Maassen Van Den Brink KI, Frings V, Van de Ven PM, Smit EF, Senan S. (2011). Outcomes of concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer and significant comorbidity. Ann Oncol 22:132-138.
24. Rube CE, Uthe D, Schmid KW, Richter KD, Wessel J, Schuck A, Willich N, Rube C. (2000). Dose-dependent induction of transforming growth factor beta (TGF-beta) in the lung tissue of fibrosis-prone mice after thoracic irradiation. Int J Radiat Oncol Biol Phys 47:1033-1042.
25. Re CE, Wilfert F, Uthe D, Kig J, Liu L, Schuck A, Willich N, Remberger K, Re C. (2004). Increased expression of proinflammatory cytokines as a cause of lung toxicity after combined treatment with gemcitabine and thoracic irradiation. Radiother Oncol 72:231-241.
26. Re CE, Wilfert F, Palm J, Kig J, Burdak-Rothkamm S, Liu L, Schuck A, Willich N, Re C. (2004). Irradiation induces a biphasic expression of pro-inflammatory cytokines in the lung. Strahlenther Onkol 180:442-448.
27. Re CE, Palm J, Erren M, Fleckenstein J, Kig J, Remberger K, Re C. (2008). Cytokine plasma levels: Reliable predictors for radiation pneumonitis PLoS ONE 3:e2898.
28. Tamai T, Uto H, Takami Y, Oda K, Saishoji A, Hashiguchi M, Kumagai K, Kure T, Mawatari S, Moriuchi A, Oketani M, Ido A, Tsubouchi H. (2011). Serum manganese superoxide dismutase and thioredoxin are potential prognostic markers for hepatitis C virus-related hepatocellular carcinoma. World J Gastroenterol 17:4890-4898.
29. Therasse P, Eisenhauer EA, Verweij J. (2006). RECIST revisited: A review of validation studies on tumour assessment. Eur J Cancer 42:1031-1039.
30. Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V, Langer C, Murphy B, Cumberlin R, Coleman CN, Rubin P. (2003). CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13:176-181.
31. Tsoutsou PG, Koukourakis MI. (2006). Radiation pneumonitis and fibrosis: Mechanisms underlying its pathogenesis and implications for future research. Int J Radiat Oncol Biol Phys 66:1281-1293.
32. Vujaskovic Z., Groen H.J., (2000) TGF-beta, radiation-induced pulmonary injury and lung cancer. Int. J. Radiat. Biol. 76. p 511-516.
33. Vujaskovic Z, Groen HJ. (2000). TGF-beta, radiation-induced pulmonary injury and lung cancer. Int J Radiat Biol 76:511-516. Werner-Wasik M, Paulus R, Curran WJ Jr, Byhardt R. (2011). Acute esophagitis and late lung toxicity in concurrent chemoradiotherapy trials in patients with locally advanced non-small-cell lung cancer: Analysis of the radiation therapy oncology group (RTOG) database. Clin Lung Cancer 12:245-251.
34. Yang M, Zhang L, Bi N, Ji W, Tan W, Zhao L, Yu D, Wu C, Wang L, Lin D. (2011). Association of P53 and ATM polymorphisms with risk of radiation-induced pneumonitis in lung cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 79:1402-1407.
35. Yin M, Liao Z, Huang YJ, Liu Z, Yuan X, Gomez D, Wang LE, Wei Q. (2011). Polymorphisms of homologous recombination genes and clinical outcomes of non-small cell lung cancer patients treated with definitive radiotherapy. PLoS ONE 6:e20055.
36. Yin M, Liao Z, Liu Z, Wang LE, Gomez D, Komaki R, Wei Q. (2011). Functional polymorphisms of base excision repair genes XRCC1 and APEX1 predict risk of radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy. Int J Radiat Oncol Biol Phys 81:e67-e73.
37. Yin M, Liao Z, Liu Z, Wang LE, O'Reilly M, Gomez D, Li M, Komaki R, Wei Q. (2011). Genetic variants of the nonhomologous end joining gene LIG4 and severe radiation pneumonitis in nonsmall cell lung cancer patients treated with definitive radiotherapy. Cancer Jun 29. [Epub ahead of print].
38. Yuan X, Liao Z, Liu Z, Wang LE, Tucker SL, Mao L, Wang XS, Martel M, Komaki R, Cox JD, Milas L, Wei Q. (2009). Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy. J Clin Oncol 27:3370-3378.
39. Zhang L, Yang M, Bi N, Fang M, Sun T, Ji W, Tan W, Zhao L, Yu D, Lin D, Wang L. (2010). ATM polymorphisms are associated with risk of radiation-induced pneumonitis. Int J Radiat Oncol Biol Phys 77:1360-1368.
40. Zhao L, Sheldon K, Chen M, Yin MS, Hayman JA, Kalemkerian GP, Arenberg D, Lyons SE, Curtis JL, Davis M, Cease KB, Brenner D, Anscher MS, Lawrence TS, Kong FM. (2008). The predictive role of plasma TGF-beta1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancer. Lung Cancer 59:232-239.